SCOPE 2023: Biopharma Insights
Murray L. Aitken, SVP of IQVIA offers insights that small biopharma organizations can take away from larger companies at the SCOPE 2023 conference in Orlando, FL.
In an interview at the 2023 SCOPE conference with ACT editor, Andy Studna, Murray L. Aitken, SVP of IQVIA discusses what small biopharma organizations can take away from larger companies.
Industry Assessment of Risk-Based Quality Management Emphasizes Value of Adoption
April 4th 2024A study conducted by the Tufts CSDD in collaboration with CluePoints and PwC revealed that slightly more than half of sponsors and contract research organizations have adopted risk-based quality management approaches.
The State of the Opioid Epidemic
March 26th 2024In part 1 of this video interview, Greg Sturmer, co-founder and CEO of Elysium Therapeutics discusses the current state of opioid usage including how pain treatment is often mismanaged and how the industry can adopt greater safety standards in developing pain therapies.
